Filed: 8/11/2025ACC: 0000950123-25-007471
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $82.14M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$82.14M
Total AUM (reported)
13.65M
Total Shares
Allocation by class
COMMON STOCK$57.89M70.5%
COMMON SHARES$24.25M29.5%
Portfolio Concentration
Top 3$64.99M79.1%
4–10$17.15M20.9%
Top 3 weight
79.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.65M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
13.65M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares5.65M
TypeSH
Market value$25.49M
31.04%
Sole
0.00
Shared
5.65M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$24.25M
29.52%
Sole
0.00
Shared
498.56K
None
0.00
Jade Biosciences, Inc.
OTRShares1.53M
TypeSH
Market value$15.24M
18.56%
Sole
0.00
Shared
1.53M
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$8.39M
10.22%
Sole
0.00
Shared
2.01M
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$3.68M
4.48%
Sole
0.00
Shared
2.65M
None
0.00
Contineum Therapeutics, Inc.
OTRShares542.63K
TypeSH
Market value$2.15M
2.62%
Sole
0.00
Shared
542.63K
None
0.00
Tempest Therapeutics, Inc.
OTRShares269.77K
TypeSH
Market value$1.83M
2.23%
Sole
0.00
Shared
269.77K
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$1.09M
1.33%
Sole
0.00
Shared
506.82K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 5.65M | SH | $25.49M 31.04% | 0.00 | 5.65M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $24.25M 29.52% | 0.00 | 498.56K | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 1.53M | SH | $15.24M 18.56% | 0.00 | 1.53M | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $8.39M 10.22% | 0.00 | 2.01M | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $3.68M 4.48% | 0.00 | 2.65M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $2.15M 2.62% | 0.00 | 542.63K | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $1.83M 2.23% | 0.00 | 269.77K | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $1.09M 1.33% | 0.00 | 506.82K | 0.00 |